FDA
-
-
-
-
-
-
-
Orphazyme A/S under In-Court-Restructuring to sell substantially all of its assets and business activities to KemPharm, Inc.
326,430 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

